Primemd (PRMD) Stock Price

Primemd Price

OTC·CLOSED
0.00
​
Market closed

Revenue has compounded at 3.2% per year over the past 5 years to 67,800.00 USD. Primemd's net margin stands at -149.1%, up from -256.9% several years earlier.

Primemd stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Primemd business model & stock analysis

Primemd, Inc. generates revenue through the delivery of professional medical services to residents in central Ohio, including physician consultations, urgent care, pediatrics, and spine and pain management. The company operates nine medical facilities such as PrimeMD - Kenton, PrimeMD - Lancaster, and PrimeMD Spine and Pain Management, billing insurance providers and patients directly for services rendered. It also provides contracted professional services to hospitals in the region, leveraging its team of physicians, nurse practitioners, physician’s assistants, and medical assistants. Revenue streams are derived from patient and insurance payments across all facility types. The company’s primary customer segments include patients seeking general medical care, urgent care, pediatric services, and specialized treatments like spine and pain management. Hospitals in central Ohio are key business clients for its contracted services. Facilities like PrimeMD - Marion Urgent Care and PrimeMD Pediatrics Dublin serve distinct patient demographics, while PrimeMD Spine and Pain Management targets patients with chronic pain conditions. Billing processes for insurance and out-of-pocket payments form the core revenue model. Revenue is generated from multiple service lines within the nine medical facilities, including urgent care centers, pediatric clinics, and specialty practices. PrimeMD - North Columbus Urgent Care and PrimeMD - Westerville cater to local communities, while PrimeMD - Newark and PrimeMD - Wilmington serve broader regional populations. The company’s billing system handles both insurance claims and direct patient payments, ensuring consistent revenue flow across all locations.

Frequently asked questions about Primemd

Converted at the current exchange rate, the Primemd share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Primemd.

The profit cannot currently be calculated for Primemd.

The P/E ratio cannot be calculated for Primemd at the moment.

The P/S cannot be calculated for Primemd currently.

The Eulerpool Quality Score for Primemd is 4/10.

The ISIN of Primemd is US74167A1016. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Primemd is PRMD. The ticker symbol is used to trade Primemd shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
67,800.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website primemd.com
Currency
USD
Initial public offering
Oct 27, 1993
ISIN
US74167A1016
Cusip
74167A101
Market capitalization
16,650.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.23 %
Last updated Nov 11, 2026, 2:38 PM

Primemd Peer Group

Primemd Ticker

OTC · PRMD

Primemd FIGI

PRMD:US · BBG000BD7DR3PRMD:PQ · BBG000BD7LT3PRMD:UV · BBG000BD7N00

All fundamentals and in-depth analysis of Primemd

Our stock analysis for Primemd stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Primemd. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.